| NCT Number | NCT07492355 |
| Lead Sponsor | Sumitomo Pharma America, Inc. |
| Conditions | Myelofibroses |
| Enrollment | 24 participants |
| Start Date | 2024-03-04 |
| Primary Completion | 2024-05-31 (estimated) |
| Study Completion | 2024-05-31 (estimated) |
| Updated on ClinicalTrials.gov | 2026-03-25 |